Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Nutrients ; 14(11)2022 May 27.
Article in English | MEDLINE | ID: mdl-35684048

ABSTRACT

Sleep is one of the most essential factors required to maintain good health. However, the global prevalence of insomnia is increasing, and caffeine intake is a major trigger. The objective of this study was to investigate the inhibitory effect of black pepper, Piper nigrum extract (PE), on caffeine-induced sleep disruption and excitation in mice. Caffeine significantly decreased sleep duration in the pentobarbital-induced sleep test. It also resulted in a significant increase in sleep onset and a decrease in non-rapid eye movement sleep. Moreover, in an open-field test, caffeine-treated mice exhibited a significantly increased time in the center zone and total distance traveled. However, the co-administration of caffeine and PE did not result in similar arousal activities. Thus, our results suggest that PE can be used as a potential therapeutic agent to treat sleep problems and excitatory status associated with caffeine intake.


Subject(s)
Piper nigrum , Animals , Caffeine/pharmacology , Mice , Pentobarbital/pharmacology , Plant Extracts/pharmacology , Sleep
2.
Nutrients ; 13(8)2021 Aug 19.
Article in English | MEDLINE | ID: mdl-34445005

ABSTRACT

Caffeine, a natural stimulant, is known to be effective for weight loss. On this basis, we screened the arousal-inducing effect of five dietary supplements with a weight loss effect (Garcinia cambogia, Coleus forskohlii, Camellia sinensis L., Irvingia gabonensis, and Malus pumila M.), of which the G. cambogia peel extract (GC) showed a significant arousal-inducing effect in the pentobarbital-induced sleep test in mice. This characteristic of GC was further evaluated by analysis of electroencephalogram and electromyogram in C57L/6N mice, and it was compared to that of the positive control, caffeine. Administration of GC (1500 mg/kg) significantly increased wakefulness and decreased non-rapid eye movement sleep, similar to that of caffeine (25 mg/kg), with GC and caffeine showing a significant increase in wakefulness at 2 and 6 h, respectively. Compared to that of caffeine, the shorter duration of efficacy of GC could be advantageous because of the lower possibility of sleep disturbance. Furthermore, the arousal-inducing effects of GC (1500 mg/kg) and caffeine (25 mg/kg) persisted throughout the chronic (3 weeks) administration study. This study, for the first time, revealed the arousal-inducing effect of GC. Our findings suggest that GC might be a promising natural stimulant with no side effects. In addition, it is preferential to take GC as a dietary supplement for weight loss during the daytime to avoid sleep disturbances owing to its arousal-inducing effect.


Subject(s)
Arousal/drug effects , Brain Waves/drug effects , Brain/drug effects , Central Nervous System Stimulants/pharmacology , Electroencephalography , Garcinia cambogia , Plant Extracts/pharmacology , Animals , Anti-Obesity Agents/pharmacology , Brain/physiology , Caffeine/pharmacology , Central Nervous System Stimulants/isolation & purification , Fruit , Garcinia cambogia/chemistry , Hypnotics and Sedatives/pharmacology , Male , Mice, Inbred C57BL , Mice, Inbred ICR , Pentobarbital/pharmacology , Plant Extracts/isolation & purification , Sleep/drug effects
3.
J Ethnopharmacol ; 104(1-2): 144-8, 2006 Mar 08.
Article in English | MEDLINE | ID: mdl-16219438

ABSTRACT

Amyloid beta protein (Abeta) may be neurotoxic during the progression of Alzheimer's disease by eliciting oxidative stress. This study was designed to determine the effect of Polygonum multiflorum Thunb water extract (PWE) on Abeta25-35-induced cognitive deficits and oxidative stress in mice. Mice were fed experimental diets comprising either 0.5 or 1% PWE for 4 weeks, and then received a single intracerebroventricular (i.c.v.) injection of Abeta25-35 (10 microg/mouse). Behavioral changes in the mice were evaluated using passive avoidance and water-maze tests. The consumption of PWE significantly ameliorated the cognitive deficits caused by i.c.v. injection of Abeta25-35. The Abeta25-35 treatment accelerated the lipid peroxidation, and PWE attenuated the Abeta-induced increase in brain levels of thiobarbituric acid reactive substances. There was an increase in glutathione peroxidase activity in PWE-treated groups. The acetylcholinesterase activity in the brain and serum was lower in PWE supplemented groups than in the only Abeta-injected group. These findings suggest that PWE exerts a preventive effect against cognitive deficits induced by Abeta25-35 accumulation in Alzheimer's disease, and that this effect is mediated by the antioxidant properties of PWE.


Subject(s)
Amyloid beta-Peptides/toxicity , Cognition Disorders/chemically induced , Cognition Disorders/drug therapy , Neuroprotective Agents/therapeutic use , Peptide Fragments/toxicity , Polygonum , Acetylcholinesterase/metabolism , Animals , Brain/drug effects , Brain/metabolism , Cognition Disorders/metabolism , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Male , Maze Learning/drug effects , Maze Learning/physiology , Mice , Mice, Inbred ICR , Neuroprotective Agents/isolation & purification , Neuroprotective Agents/pharmacology , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Roots , Reaction Time/drug effects , Reaction Time/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...